COMMUNIQUÉS West-GlobeNewswire

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024

11/03/2025 - 21:27

Raanana, Israel, March 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, [...]

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11/03/2025 - 21:28

BRISBANE, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on March 6, 2025, the Compensation Committee granted inducement awards consisting of a non-qualified stock [...]

Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update

11/03/2025 - 21:30

ZUG, Switzerland, March 11, 2025 (GLOBE NEWSWIRE) -- Successful 2024 marked by significant clinical advancements across Oculis’ late-stage and highly differentiated clinical pipeline targeting retina (OCS-01 in diabetic [...]

Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update

11/03/2025 - 21:30

Successful 2024 marked by significant clinical advancements across Oculis’ late-stage and highly differentiated clinical pipeline targeting retina (OCS-01 in diabetic macular edema), neuro-ophthalmic (Privosegtor, OCS- [...]

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

11/03/2025 - 21:40

AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches: COHERE™ ALIF Spacer : The first Porous PEEK™ [...]

Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures

11/03/2025 - 22:00

VANCOUVER, British Columbia, March 11, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: DCNN) (OTCPK: AGFAD), a company focused on opportunities within and outside of the cannabis [...]

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

10/03/2025 - 14:00

Southlake, TX, March 10, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company focused on transforming [...]

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

10/03/2025 - 14:14

GAITHERSBURG, Md., March 10, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility to [...]

BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System

10/03/2025 - 14:15

SUNNYVALE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- BioCardia ® , Inc . [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today [...]

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

10/03/2025 - 14:15

Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 10 mars 2025 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

10/03/2025 - 14:17

Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 10 mars 2025 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

PharmAla Signs Duchefa Farma as Exclusive Distributor in Netherlands

10/03/2025 - 14:24

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]

First Patient Enrolled in Merit Medical’s PREEMIE Study

10/03/2025 - 14:25

Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants SOUTH JORDAN, Utah, March 10, 2025 (GLOBE NEWSWIRE [...]

Transactions under Novonesis’ share buyback program

10/03/2025 - 15:08

Please read the announcement in PDF Attachment 2025_10_Share_buyback_program

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38

10/03/2025 - 15:13

Company Announcement Johnson & Johnson has decided that it will not exercise its option to receive a worldwide license to develop, manufacture and commercialize HexaBody-CD38 Genmab will not pursue further clinical [...]

Dogecoin Cash, Inc. ($CBDS) Expands into Meme Coin Market with Formation of MEME COINS Inc.

10/03/2025 - 15:30

MESQUITE, NV, March 10, 2025 (GLOBE NEWSWIRE) -- March 10, 2025 – Mesquite, NV – Dogecoin Cash, Inc. ($CBDS), a publicly traded leader in blockchain innovation, is excited to announce its strategic expansion into the [...]

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

10/03/2025 - 16:00

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 10 March 2025 at 17.00 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]

Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

10/03/2025 - 16:00

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair at the American Academy of Orthopaedic Surgeons Annual [...]

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board

10/03/2025 - 16:18

Psyence Group settles Debt for Shares TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group " or the " Company ") (CSE: PSYG) is pleased that its NASDAQ-listed associate, Psyence Biomedical Ltd [...]